• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰1型神经纤维瘤病女性患者对乳腺癌风险的(未)认知情况。

Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland.

作者信息

Karwacki Marek W

机构信息

Coordinated Medical Care Center for Neurofibromatoses and related RASopathies, Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland.

出版信息

Contemp Oncol (Pozn). 2020;24(2):140-144. doi: 10.5114/wo.2020.97637. Epub 2020 Jul 3.

DOI:10.5114/wo.2020.97637
PMID:32774141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403769/
Abstract

The main goal of this study was to draw the attention of physicians to commonly undisclosed risk of breast cancer (BrCa) in women suffering from neurofibromatosis type 1 (NF-1), which is 5-fold higher than in the general population. NF-1 related BrCa arises earlier (< 50 years) and is more advanced, with an increased mortality. NF-1 is one of the most frequent monogenic diseases worldwide and a tumor predisposition syndrome. The gene is an important negative regulator of the Ras oncogene and belongs to the family of the 12 the most important BrCa predisposition genes. Planning introduction of BrCa screening guidelines for NF-1 women in Poland we started with assessment of BrCa risk awareness and current preventive practices in this population by a survey published in an open access internet profile dedicated exclusively to patients with NF-1 in Poland, with 1928 participants. As a result, we revealed that the awareness of this specific risk was declared by only 30% out of 138 responders, and only 21% of them received this information from medical professionals. In all 4 (2.89%) women suffering from BrCa the cancer was diagnosed before the 50 year of age. It exceeds significantly the expected prevalence of BrCa in the general population of Polish women. We conclude that the limited awareness of NF-1 related BrCa risk in Polish patients warrants the educational effort directed both to the NF-1 patients by professional counseling and to the medical community, in order to increase the efficacy of preventive measures and decrease BrCa mortality.

摘要

本研究的主要目的是引起医生对1型神经纤维瘤病(NF-1)女性中常见的未公开的乳腺癌(BrCa)风险的关注,该风险比普通人群高5倍。与NF-1相关的BrCa发病较早(<50岁)且病情更严重,死亡率更高。NF-1是全球最常见的单基因疾病之一,也是一种肿瘤易感性综合征。该基因是Ras癌基因的重要负调控因子,属于12个最重要的BrCa易感基因家族。在波兰计划为NF-1女性引入BrCa筛查指南时,我们首先通过在波兰一个专门为NF-1患者设立的开放获取互联网平台上发布的一项调查,评估了该人群对BrCa风险的认识和当前的预防措施,共有1928名参与者。结果显示,在138名受访者中,只有30%的人表示知晓这一特定风险,其中只有21%的人从医疗专业人员那里获得了这一信息。在所有4名(2.89%)患有BrCa的女性中,癌症在50岁之前被诊断出来。这显著超过了波兰女性普通人群中BrCa的预期患病率。我们得出结论,波兰患者对与NF-1相关的BrCa风险认识有限,因此有必要通过专业咨询对NF-1患者和医疗界进行教育,以提高预防措施的效果并降低BrCa死亡率。

相似文献

1
Breast cancer risk (un)awareness among women suffering from neurofibromatosis type 1 in Poland.波兰1型神经纤维瘤病女性患者对乳腺癌风险的(未)认知情况。
Contemp Oncol (Pozn). 2020;24(2):140-144. doi: 10.5114/wo.2020.97637. Epub 2020 Jul 3.
2
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.
3
Prevalence of BRCA1 and BRCA2 Mutations Among High-risk Bahraini Patients with Breast Cancer.BRCA1 和 BRCA2 基因突变在高风险巴林乳腺癌患者中的流行率。
Gulf J Oncolog. 2023 May;1(42):22-25.
4
5
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.女性 BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Feb 18;160(4):271-81. doi: 10.7326/M13-2747.
6
Recognizing BRCA gene mutation risk subsequent to breast cancer diagnosis in southwestern Ontario.在安大略省西南部诊断出乳腺癌后识别 BRCA 基因突变风险。
Can Fam Physician. 2012 May;58(5):e258-66.
7
BRCA-Related Cancer Genetic Counseling is Indicated in Many Women Seeking Primary Care.BRCA 相关癌症遗传咨询在许多寻求初级保健的女性中是有指征的。
J Am Board Fam Med. 2020 Nov-Dec;33(6):885-893. doi: 10.3122/jabfm.2020.06.190461.
8
BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18-64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas - United States, 2009-2014.2009 - 2014年美国非大都市和大都市地区18 - 64岁参加雇主赞助医疗保险的女性的BRCA基因检测及预防性干预措施的接受情况
MMWR Surveill Summ. 2017 Sep 8;66(15):1-11. doi: 10.15585/mmwr.ss6615a1.
9
"High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis".对携带BRCA1/2基因的高危乳腺癌患者进行筛查可实现早期诊断,并改善乳腺癌确诊后的生存率。
Front Oncol. 2021 Sep 2;11:683656. doi: 10.3389/fonc.2021.683656. eCollection 2021.
10
Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result.意大利无意义 BRCA 检测结果女性的护士主导遗传咨询途径的经验。
J Genet Couns. 2023 Feb;32(1):140-152. doi: 10.1002/jgc4.1630. Epub 2022 Aug 29.

引用本文的文献

1
Beliefs, screening attitudes and breast cancer awareness of young women with neurofibromatosis type 1: A reflexive thematic analysis.1型神经纤维瘤病年轻女性的信念、筛查态度及乳腺癌认知:一项反思性主题分析
J Health Psychol. 2025 Mar;30(3):369-383. doi: 10.1177/13591053241255053. Epub 2024 Jun 10.
2
Mammographic breast density and IGF-1 gene polymorphisms rs1520220, rs2946834 and rs6219 in Polish women.波兰女性乳腺钼靶密度与IGF-1基因多态性rs1520220、rs2946834和rs6219
Contemp Oncol (Pozn). 2021;25(3):191-197. doi: 10.5114/wo.2021.109727. Epub 2021 Oct 5.

本文引用的文献

1
Coordinated medical care for children with neurofibromatosis type 1 and related RASopathies in Poland.波兰1型神经纤维瘤病及相关RAS病患儿的协调医疗护理。
Arch Med Sci. 2019 May 17;17(5):1221-1231. doi: 10.5114/aoms.2019.85143. eCollection 2021.
2
Variation in Prevalence of Rare Heritable Traits - A Simulation Study - Illustrated by Neurofibromatosis Type 1.罕见遗传性状患病率的变异——一项模拟研究——以1型神经纤维瘤病为例
Twin Res Hum Genet. 2019 Aug;22(4):229-232. doi: 10.1017/thg.2019.47. Epub 2019 Jul 25.
3
Health Supervision for Children With Neurofibromatosis Type 1.
1 型神经纤维瘤病患儿的健康监督
Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2019-0660.
4
Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness.神经纤维瘤病中的致病性突变鉴定出一个富含亮氨酸的结构域,该结构域调节神经胶质瘤细胞的侵袭性。
Oncogene. 2019 Jul;38(27):5367-5380. doi: 10.1038/s41388-019-0809-3. Epub 2019 Apr 9.
5
Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.1型神经纤维瘤病女性患乳腺癌风险增加:一项文献荟萃分析与系统评价
Hered Cancer Clin Pract. 2019 Mar 25;17:12. doi: 10.1186/s13053-019-0110-z. eCollection 2019.
6
European cancer mortality predictions for the year 2019 with focus on breast cancer.2019 年欧洲癌症死亡率预测,重点关注乳腺癌。
Ann Oncol. 2019 May 1;30(5):781-787. doi: 10.1093/annonc/mdz051.
7
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
8
Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).神经纤维瘤病 1 型成人护理:美国医学遗传学与基因组学学院(ACMG)的临床实践资源。
Genet Med. 2018 Jul;20(7):671-682. doi: 10.1038/gim.2018.28. Epub 2018 Apr 26.
9
Prevalence of neurofibromatosis type 1 in the Finnish population.芬兰人群中 1 型神经纤维瘤病的患病率。
Genet Med. 2018 Sep;20(9):1082-1086. doi: 10.1038/gim.2017.215. Epub 2017 Dec 7.
10
Trends and predictions to 2020 in breast cancer mortality in Europe.欧洲乳腺癌死亡率的趋势和预测到 2020 年。
Breast. 2017 Dec;36:89-95. doi: 10.1016/j.breast.2017.06.003. Epub 2017 Oct 4.